UY25600A1 - PROTECTIVE ANTIGENS AGAINST ECHINOCOCCUS GRANULOSUS INFECTION AND VACCINES CONTAINING SUCH ANTIGENS - Google Patents

PROTECTIVE ANTIGENS AGAINST ECHINOCOCCUS GRANULOSUS INFECTION AND VACCINES CONTAINING SUCH ANTIGENS

Info

Publication number
UY25600A1
UY25600A1 UY25600A UY25600A UY25600A1 UY 25600 A1 UY25600 A1 UY 25600A1 UY 25600 A UY25600 A UY 25600A UY 25600 A UY25600 A UY 25600A UY 25600 A1 UY25600 A1 UY 25600A1
Authority
UY
Uruguay
Prior art keywords
antigens
vaccines containing
echinococcus granulosus
protective
granulosus infection
Prior art date
Application number
UY25600A
Other languages
Spanish (es)
Inventor
Heath David Lawrence Ste David
Original Assignee
Pastoral Agric Res Inst Nz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pastoral Agric Res Inst Nz Ltd filed Critical Pastoral Agric Res Inst Nz Ltd
Publication of UY25600A1 publication Critical patent/UY25600A1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Polipéptido antigénico purificado con un peso molecular en el entorno de 23 a 25 kd calculado por sds-page que incluye la secuencia de aminoácidos descripta en la solicitud y que puede generar una respuesta inmunitaria protectora a la infección por granulosus en un huesped susceptible; o un fragmento o variante peptídico con una actividad inmunitaria protectora sustancialmente equivalente a la de éste.Purified antigenic polypeptide with a molecular weight in the environment of 23 to 25 kd calculated by sds-page that includes the amino acid sequence described in the application and that can generate a protective immune response to granulosus infection in a susceptible host; or a peptide fragment or variant with a protective immune activity substantially equivalent to that of it.

UY25600A 1997-03-10 1999-07-06 PROTECTIVE ANTIGENS AGAINST ECHINOCOCCUS GRANULOSUS INFECTION AND VACCINES CONTAINING SUCH ANTIGENS UY25600A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ24960097 1997-03-10

Publications (1)

Publication Number Publication Date
UY25600A1 true UY25600A1 (en) 2001-08-27

Family

ID=38812112

Family Applications (1)

Application Number Title Priority Date Filing Date
UY25600A UY25600A1 (en) 1997-03-10 1999-07-06 PROTECTIVE ANTIGENS AGAINST ECHINOCOCCUS GRANULOSUS INFECTION AND VACCINES CONTAINING SUCH ANTIGENS

Country Status (1)

Country Link
UY (1) UY25600A1 (en)

Similar Documents

Publication Publication Date Title
FI950405A (en) Conjugates of weakly immunogenic antigens and synthetic peptide carriers and vaccines containing them
DE69434295D1 (en) Of human T-cells immunodominant epitopes of the virus of C-hepatitis
ATE64601T1 (en) LYMPHADENOPATHY-ASSOCIATED ENVELOPE ANTIGENS AND THEIR USES.
ES2100240T3 (en) BACTERIOPHAGUS MODIFIED BY GENETIC ENGINEERING AND VACCINES THAT CONTAIN THEM.
FR2697022B1 (en) Plasmodium falciparum antigens capable of inducing protective antibodies with broad spectrum - Application to vaccination.
LU91149I2 (en) Combination of diphtheria toxoid, tetanus toxoid, pertussis toxoid, filamentous hemagglutinin, pertactin, and hepatitis B virus (protein S) recombinant surface antigen.
ATE80310T1 (en) ANTIGENIC PROTEINS, VACCINES CONTAINING THE SAME, PROTECTIVE ANTIBODIES ON THE OTHER HAND FOR THE PREVENTION OF COCCIDIOSIS CAUSED BY EIMERIA TENELLA.
MX9300787A (en) PEPTIDE TO DIAGNOSE AND IMMUNIZE AGAINST T. CRUZI INFECTION.
DE69317435T2 (en) ANTI-INFLAMMATORY TOLEROGENIC AND INMONOINHIBITORIC PROPERTIES OF CARBOHYHYDRATE BINDING PEPTIDES
DE69007571D1 (en) HIV peptide fragments.
ATE137672T1 (en) SYNTHETIC PEPTIDES DERIVED FROM THE STREPTOCOCCUS M PROTEIN AND VACCINES PRODUCED THEREFROM
UY25600A1 (en) PROTECTIVE ANTIGENS AGAINST ECHINOCOCCUS GRANULOSUS INFECTION AND VACCINES CONTAINING SUCH ANTIGENS
CA2158024A1 (en) A mycoplasma gallisepticum antigen, dna encoding the antigen, recombinant vector bearing the dna and recombinant virus utilizing the recombinant vector as well as use thereof
KR910011897A (en) Malaria vaccine
ATE422503T1 (en) RECOMBINANT POLYPEPTIDES FROM MYCOPLASMA AND VACCINES
ES2081607T3 (en) VACCINE AGAINST NEMATODES.
ES2160594T3 (en) PROTECTIVE ANTIGENS AGAINST INFECTION WITH ECHINOCOCCUS GRANULOSUS AND VACCINES CONTAINING THESE ANTIGENS.
DK1005487T3 (en) Outer 74 kD membrane protein from Moraxella catarrhalis
EP0492500A3 (en) Protecting plasmodium falciparum hybrid proteins, containing partial sequences of malaria antigens hrpii and serp
ES2042481T1 (en) SYNTHETIC PEPTIDES DERIVED FROM THE HBC ANTIGEN FROM HEPATITIS B VIRUS.
DE60022995D1 (en) VACCINE
DK43991D0 (en) GENERAL PLASTS OF PLASMODIUM FALCIPARUM MEROZOIT SURFACE ANTIGEN
KR970074790A (en) Pseudomonas vaccines containing synthetic peptides and therapeutic agents produced therefrom
UY23633A1 (en) PROTECTIVE ANTIGENS AGAINST ECHINOCOCCUS GRANULOSUS INFECTION AND VACCINES CONTAINING SUCH ANTIGENS
ES2051152B1 (en) PROCEDURE OF SYSTESIS OF PEPTIDES WITH THE CAPACITY TO DETECT ANTI-BODIES ANTI-VIRUSES OF HEPATITIS C (HCV) IN SERUM OF AFFECTED INDIVIDUALS.